Literature DB >> 35927362

Synthetic double inversion recovery (DIR) and phase-sensitive inversion recovery (PSIR) images showed better delineation of multiple sclerosis plaques.

Moto Nakaya1,2, Akifumi Hagiwara3,4, Masaaki Hori1,5, Kazumasa Yokoyama6, Shohei Fujita1,2, Christina Andica1,7, Koji Kamagata1, Yasunobu Hoshino6, Yuji Tomizawa6, Nobutaka Hattori6, Shigeki Aoki1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35927362     DOI: 10.1007/s00234-022-03031-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.995


× No keyword cloud information.
  5 in total

1.  Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging.

Authors:  F Nelson; A H Poonawalla; P Hou; F Huang; J S Wolinsky; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

2.  Synthetic MRI in the Detection of Multiple Sclerosis Plaques.

Authors:  A Hagiwara; M Hori; K Yokoyama; M Y Takemura; C Andica; T Tabata; K Kamagata; M Suzuki; K K Kumamaru; M Nakazawa; N Takano; H Kawasaki; N Hamasaki; A Kunimatsu; S Aoki
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-08       Impact factor: 3.825

3.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.

Authors:  Jeroen J G Geurts; Petra J W Pouwels; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof; Jonas A Castelijns
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

4.  Response to the letter synthetic double inversion recovery (DIR) and phase-sensitive inversion recovery (PSIR) images showed better delineation of multiple sclerosis plaques.

Authors:  Francesc Xavier Aymerich; Àlex Rovira
Journal:  Neuroradiology       Date:  2022-10       Impact factor: 2.995

5.  3D Quantitative Synthetic MRI in the Evaluation of Multiple Sclerosis Lesions.

Authors:  S Fujita; K Yokoyama; A Hagiwara; S Kato; C Andica; K Kamagata; N Hattori; O Abe; S Aoki
Journal:  AJNR Am J Neuroradiol       Date:  2021-01-07       Impact factor: 3.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.